[{"address1": "15110 North Dallas Parkway", "address2": "Suite 600", "city": "Dallas", "state": "TX", "zip": "75248", "country": "United States", "phone": "(214) 242-9619", "website": "https://www.mangoceuticals.com", "industry": "Health Information Services", "industryKey": "health-information-services", "industryDisp": "Health Information Services", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Mangoceuticals, Inc. develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com. Mangoceuticals, Inc. has a marketing agreement with Marius Pharmaceuticals, LLC to market and sell KYZATREX, an oral testosterone replacement therapy product under the PRIME program. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.", "fullTimeEmployees": 3, "companyOfficers": [{"maxAge": 1, "name": "Mr. Jacob D. Cohen", "age": 44, "title": "Co-Founder, CEO & Chairman", "yearBorn": 1979, "fiscalYear": 2023, "totalPay": 278000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eugene M. Johnston", "age": 59, "title": "Chief Financial Officer", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 14000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Amanda Elizabeth Hammer", "age": 37, "title": "Chief Operating Officer", "yearBorn": 1986, "fiscalYear": 2023, "totalPay": 105417, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.2575, "open": 0.2431, "dayLow": 0.2311, "dayHigh": 0.2521, "regularMarketPreviousClose": 0.2575, "regularMarketOpen": 0.2431, "regularMarketDayLow": 0.2311, "regularMarketDayHigh": 0.2521, "volume": 94757, "regularMarketVolume": 94757, "averageVolume": 813973, "averageVolume10days": 138240, "averageDailyVolume10Day": 138240, "marketCap": 5985000, "fiftyTwoWeekLow": 0.143, "fiftyTwoWeekHigh": 2.38, "priceToSalesTrailing12Months": 8.181896, "fiftyDayAverage": 0.22564, "twoHundredDayAverage": 0.61217, "currency": "USD", "enterpriseValue": 4973558, "floatShares": 13602308, "sharesOutstanding": 24619500, "sharesShort": 197620, "sharesShortPriorMonth": 149057, "sharesShortPreviousMonthDate": 1710460800, "dateShortInterest": 1713139200, "sharesPercentSharesOut": 0.008, "heldPercentInsiders": 0.42444, "heldPercentInstitutions": 0.00434, "shortRatio": 0.18, "shortPercentOfFloat": 0.0135, "impliedSharesOutstanding": 24770100, "bookValue": 0.036, "priceToBook": 6.752778, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -9212417, "trailingEps": -0.57, "enterpriseToRevenue": 6.799, "enterpriseToEbitda": -0.615, "52WeekChange": -0.80243903, "SandP52WeekChange": 0.23099434, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "MGRX", "underlyingSymbol": "MGRX", "shortName": "Mangoceuticals, Inc.", "longName": "Mangoceuticals, Inc.", "firstTradeDateEpochUtc": 1679405400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "7f6dcdde-b034-3a5b-bb77-bae89f162a95", "messageBoardId": "finmb_1787930606", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.2431, "recommendationKey": "none", "totalCash": 739006, "totalCashPerShare": 0.032, "ebitda": -8093536, "totalDebt": 128679, "quickRatio": 3.501, "currentRatio": 3.878, "totalRevenue": 731493, "debtToEquity": 16.609, "revenuePerShare": 0.045, "returnOnAssets": -4.94043, "returnOnEquity": -13.26688, "freeCashflow": -2854273, "operatingCashflow": -6997375, "revenueGrowth": 26.338, "grossMargins": 0.58989, "operatingMargins": -7.64231, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-05-01"}]